Cited by 69

The DOI matches its Crossref record.

Opsonins: Their function, identity, and clinical significance

Winkelstein, Jerry A.·1973·The Journal of Pediatrics

Overview

Integrity signals

Registry

Crossref · 10.1016/s0022-3476(73)80062-9

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 41

  1. Wood, 1951, Studies on the cellular immunology of acute bacterial infections, Harvey Lect., 47, 72
  2. Shin, 1968, Chemotactic and anaphylotoxic fragment cleaved from the fifth component of guinea pig complement, Science, 162, 361, 10.1126/science.162.3851.361 · DOI
  3. Ward, 1966, Further studies on the chemotactic factor of complement and its formation in vivo, Immunology, 11, 141
  4. Horwitz, 1971, Use of leukocyte chemotaxis in vitro to assay mediators generated by immune reactions, J. Immunol., 106, 649, 10.4049/jimmunol.106.3.649 · DOI
  5. Wright, 1903, An experimental investigation of the role of the blood fluids in connection with phagocytosis, Proc. R. Soc. Ser. B. Biol. Sci., 72, 357, 10.1098/rspl.1903.0062 · DOI
  6. Ward, 1933, An analysis of the opsonic and tropic action of normal and immune sera based on experiments with the pneumococcus, J. Exp. Med., 57, 527, 10.1084/jem.57.4.527 · DOI
  7. Slopek, 1962, The role of complement and natural antibodies in the process of phagocytosis, Arch. Immunol. Ther. Exp. (Warsz.), 10, 559
  8. Sterzl, 1964, The opsonic activity of complement in sera without antibody, Folia Microbiol. (Praha), 8, 240, 10.1007/BF02872588 · DOI
  9. Hirsch, 1964, Studies on heat labile opsonin in rabbit serum, J. Immunol., 92, 145, 10.4049/jimmunol.92.1.145 · DOI
  10. Wood, 1941, Studies on the mechanism of recovery in pneumococcal pneumonia. I. The action of type specific antibody upon the pulmonary lesion of experimentalpneumonia, J. Exp. Med., 73, 201, 10.1084/jem.73.2.201 · DOI
  11. Rowley, 1966, Number of molecules of antibody required to promote phagocytosis of one bacterium, Nature, 210, 496, 10.1038/210496a0 · DOI
  12. Biozzi, 1961, Measurement of the opsonic effect of normal and immune sera on the phagocytosis of Salmonella typhi by the reticuloendothelial system, J. Immunol., 87, 296, 10.4049/jimmunol.87.3.296 · DOI
  13. Smith, 1967, Comparison of the opsonic activity of gamma G and gamma M anti-proteus globulins, J. Immunol., 98, 336, 10.4049/jimmunol.98.2.336 · DOI
  14. Robbins, 1968, The isolation and biological activities of rabbit gamma M and gamma G anti-Salmonella typhimurium antibodies, J. Exp. Med., 128, 553
  15. Quie, 1968, Phagocytosis in subacute bacterial endocarditis: Localization of the primary opsonic site to the Fc fragment, J. Exp. Med., 128, 553, 10.1084/jem.128.4.553 · DOI
  16. Messner, 1970, Receptors for human gamma G globulin on human neutrophils, J. Clin. Invest., 49, 2165, 10.1172/JCI106435 · DOI
  17. Johnston, 1969, The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors, J. Exp. Med., 129, 1275, 10.1084/jem.129.6.1275 · DOI
  18. Lay, 1968, Receptors for complement on leukocytes, J. Exp. Med., 128, 991, 10.1084/jem.128.5.991 · DOI
  19. Huber, 1968, Human monocytes: Distinct receptor sites for the third component of complement and for immunoglobulin G, Science, 162, 1281, 10.1126/science.162.3859.1281 · DOI
  20. Smith, 1969, Heat labile opsonins to pneumococcus. I. Participation of complement, J. Exp. Med., 130, 1209, 10.1084/jem.130.6.1209 · DOI
  21. Winkelstein, 1972, Heat labile opsonins to pneumococcus. III. The participation of immunoglobulin and of the alternate pathway of C3 activation, J. Immunol., 108, 1681, 10.4049/jimmunol.108.6.1681 · DOI
  22. Shin, 1969, Heat labile opsonins to pneumococcus. II. Involvement of C3 and C5, J. Exp. Med., 130, 1229, 10.1084/jem.130.6.1229 · DOI
  23. Jason, 1972, Human heat labile opsonins: Evidence for their mediation via the alternate pathway of complement activation, J. Immunol., 109, 26, 10.4049/jimmunol.109.1.26 · DOI
  24. Johnson, 1972, Opsonic activity in human serum deficient in C2, J. Immunol., 109, 141, 10.4049/jimmunol.109.1.141 · DOI
  25. Pillemer, 1954, The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena, Science, 120, 279, 10.1126/science.120.3112.279 · DOI
  26. Marcus, 1971, An alternate complement pathway: C3 cleaving activity, not due to C4, 2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum: Relation to properdin, Proc. Natl. Acad. Sci. U. S. A., 68, 1351, 10.1073/pnas.68.6.1351 · DOI
  27. Ruddy, 1972, The complement system of man, N. Engl. J. Med., 287, 489, 10.1056/NEJM197209072871005 · DOI
  28. Forman, 1969, Impaired opsonic activity but normal phagocytosis in low-birth-weight infants, N. Engl. J. Med., 281, 926, 10.1056/NEJM196910232811704 · DOI
  29. McCracken, 1971, Leukocyte function and the development of opsonic and complement activity in the neonate, Am. J. Dis. Child., 121, 121
  30. Dossett, 1969, Studies on interaction of bacteria, serum factors and polymorphonuclear leukocytes in mothers and newborns, Pediatrics, 44, 49, 10.1542/peds.44.1.49 · DOI
  31. Robinson, 1966, Pneumococcal meningitis in sickle cell anemia, N. Engl. J. Med., 274, 1006, 10.1056/NEJM196605052741806 · DOI
  32. Winkelstein, 1968, Deficiency of pneumococcal serum opsonizing activity in sickle cell disease, N. Engl. J. Med., 279, 459, 10.1056/NEJM196808292790904 · DOI
  33. Robbins, 1965, Normal response of sickle cell anemia patients to immunization with Salmonella vaccines, J. Pediatr., 66, 877, 10.1016/S0022-3476(65)80062-2 · DOI
  34. Johnston, 1972, Deficient serum opsonins in sickle cell disease, Pediatr. Res., 6, 381
  35. Pearson, 1969, Functional asplenia in sickle cell anemia, N. Engl. J. Med., 291, 923, 10.1056/NEJM196910232811703 · DOI
  36. Shulkind, 1967, Effect of antibody upon clearance of I-125-labelled pneumococci by spleen and liver, Pediatr. Res., 1, 178, 10.1203/00006450-196705000-00004 · DOI
  37. Alper, 1970, Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3), N. Engl. J. Med., 282, 349, 10.1056/NEJM197002122820701 · DOI
  38. Alper, 1970, Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection, J. Clin. Invest., 49, 1975, 10.1172/JCI106417 · DOI
  39. Miller, 1969, A familial, plasma-associated defect of phagocytosis, Lancet, 2, 60
  40. Miller, 1970, A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5), N. Engl. J. Med., 282, 354, 10.1056/NEJM197002122820702 · DOI
  41. Jacobs, 1972, Fatal familial Lenier's disease: A deficiency of the opsonic activity of serum complement, Pediatrics, 49, 225, 10.1542/peds.49.2.225 · DOI

Cited by

Sorted by citations

Metadata

Authors
Winkelstein, J. A.
Venue
The Journal of Pediatrics
Publisher
Elsevier BV
Published
1973-05
Volume
82
Issue
5
Pages
747-753
ISSN
0022-3476
Cited by
69
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review